N - formyl hydroxylamine compounds as PDF inhibitors

Details for Australian Patent Application No. 2006251612 (hide)

Owner Novartis AG Vicuron Pharmaceuticals Inc.

Inventors Lee, Kwangho; Bushell, Simon; Seepersaud, Mohindra; Jain, Rakesh K.; Yuan, Zhengyu; Francavilla, Charles; Shu, Lei; Sundaram, Arathia; Bracken, Kathryn Rene; Dean, Karl

Agent Davies Collison Cave

Pub. Number AU-B-2006251612

PCT Pub. Number WO2006/127576

Priority 60/683,655 23.05.05 US

Filing date 22 May 2006

Wipo publication date 30 November 2006

Acceptance publication date 20 May 2010

International Classifications

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

29 November 2007 PCT application entered the National Phase

  PCT publication WO2006/127576 Priority application(s): WO2006/127576

20 May 2010 Application Accepted

  Published as AU-B-2006251612

16 September 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006251615-Membrane filtration of a product

2006251610-Method for the treatment of noise phobia in companion animals